1 / 4

Human Insulin Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2015

Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells.

buntypatil
Télécharger la présentation

Human Insulin Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hexa Reports Market Research Reports and Insightful Company Profiles Human Insulin Market for Tablets Market Share, Size, Industry Profile, Market Prize, Forecast and Overview 2015 About diabetes Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy. Technavio's analysts forecast the global human insulin market to grow at a CAGR of 10.29% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes. Browse Detail Report With TOC @http://www.hexareports.com/report/global-human-insulin- market-2015-2019/details

  2. Hexa Reports Market Research Reports and Insightful Company Profiles Technavio's report, Global Human Insulin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market. Key vendors Eli Lilly Novo Nordisk Sanofi Other prominent vendors Biocon Biodel Biogenomics Boehringer Ingelheim Bristol-Myers Squibb Diamyd Medical Diasome Pharmaceuticals DiaVacs Pfizer Generex Biotechnology Lexicon Pharmaceuticals Macrogenics Merck Oramed Pharmaceuticals Osiris Therapeutics Thermalin Diabetes Tolerion Wockhardt XOMA Corporation Market driver Increase in prevalence of diabetes For a full, detailed list, view our report Market challenge Stringent regulatory environment For a full, detailed list, view our report Market trend Increasing R&D for novel mechanisms For a full, detailed list, view our report

  3. Hexa Reports Market Research Reports and Insightful Company Profiles Key questions answered in this report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Table Of Content PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Product profiles PART 04: Market research methodology Research methodology Economic indicators PART 05: Disease overview Epidemiology PART 06: Pipeline analysis Request A Sample copy of This Report @ http://www.hexareports.com/sample/45938 PART 07: Introduction Key market highlights PART 08: Market landscape Market overview Market size and forecast Five forces analysis PART 09: Market segmentation by type of insulin Fast-acting insulin Intermediate-acting insulin Long-acting insulin PART 10: Market segmentation by type of disease PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges

  4. Hexa Reports Market Research Reports and Insightful Company Profiles PART 15: Impact of drivers and challenges Browse Full Report @ http://www.hexareports.com/report/global-human-insulin-market-2015- 2019/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/

More Related